| Symbol |
Name |
|
AATF
|
apoptosis antagonizing transcription factor
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APTX
|
aprataxin
|
|
AQP4
|
aquaporin 4
|
|
AQP5
|
aquaporin 5
|
|
AR
|
androgen receptor
|
|
ARFIP2
|
ADP-ribosylation factor interacting protein 2
|
|
ARHGDIA
|
Rho GDP dissociation inhibitor (GDI) alpha
|
|
ATF4
|
activating transcription factor 4
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP5H
|
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit d
|
|
ATXN1
|
ataxin 1
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AXIN1
|
axin 1
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BANP
|
BTG3 associated nuclear protein
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL2L12
|
BCL2-like 12 (proline rich)
|
|
BCR
|
breakpoint cluster region
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BMX
|
BMX non-receptor tyrosine kinase
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
CACNA1H
|
calcium channel, voltage-dependent, T type, alpha 1H subunit
|
|
CALY
|
calcyon neuron-specific vesicular protein
|
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha
|
|
CAMK2B
|
calcium/calmodulin-dependent protein kinase II beta
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CCDC6
|
coiled-coil domain containing 6
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCND1
|
cyclin D1
|
|
CD28
|
CD28 molecule
|
|
CDC25C
|
cell division cycle 25C
|
|
CDCA8
|
cell division cycle associated 8
|
|
CDCP1
|
CUB domain containing protein 1
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CELF1
|
CUGBP, Elav-like family member 1
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CIB1
|
calcium and integrin binding 1 (calmyrin)
|
|
COL4A3BP
|
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein
|
|
COPS6
|
COP9 signalosome subunit 6
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAB
|
crystallin, alpha B
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNND1
|
catenin (cadherin-associated protein), delta 1
|
|
CTTN
|
cortactin
|
|
CUX1
|
cut-like homeobox 1
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYSLTR1
|
cysteinyl leukotriene receptor 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DCK
|
deoxycytidine kinase
|
|
DDX5
|
DEAD (Asp-Glu-Ala-Asp) box helicase 5
|
|
DEPTOR
|
DEP domain containing MTOR-interacting protein
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
DLG4
|
discs, large homolog 4 (Drosophila)
|
|
DNM2
|
dynamin 2
|
|
DNPH1
|
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
|
|
DOCK1
|
dedicator of cytokinesis 1
|
|
DUT
|
deoxyuridine triphosphatase
|
|
EEF2
|
eukaryotic translation elongation factor 2
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EP300
|
E1A binding protein p300
|
|
EPHA3
|
EPH receptor A3
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERN1
|
endoplasmic reticulum to nucleus signaling 1
|
|
ESR1
|
estrogen receptor 1
|
|
EZR
|
ezrin
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FBXL2
|
F-box and leucine-rich repeat protein 2
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3
|
|
GABRG2
|
gamma-aminobutyric acid (GABA) A receptor, gamma 2
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA4
|
GATA binding protein 4
|
|
GCM1
|
glial cells missing homolog 1 (Drosophila)
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLRA3
|
glycine receptor, alpha 3
|
|
GLUL
|
glutamate-ammonia ligase
|
|
GORASP2
|
golgi reassembly stacking protein 2, 55kDa
|
|
GPHN
|
gephyrin
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GUK1
|
guanylate kinase 1
|
|
GYS1
|
glycogen synthase 1 (muscle)
|
|
H2AFX
|
H2A histone family, member X
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HDAC5
|
histone deacetylase 5
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
HTT
|
huntingtin
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
INSR
|
insulin receptor
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISYNA1
|
inositol-3-phosphate synthase 1
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
JAK1
|
Janus kinase 1
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
KAT7
|
K(lysine) acetyltransferase 7
|
|
KCNK3
|
potassium channel, two pore domain subfamily K, member 3
|
|
KDR
|
kinase insert domain receptor
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KRT18
|
keratin 18, type I
|
|
LAT
|
linker for activation of T cells
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEPR
|
leptin receptor
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LRP6
|
low density lipoprotein receptor-related protein 6
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAF1
|
MAF1 homolog (S. cerevisiae)
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K5
|
mitogen-activated protein kinase kinase kinase 5
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPT
|
microtubule-associated protein tau
|
|
MCTS1
|
malignant T cell amplified sequence 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MPZL1
|
myelin protein zero-like 1
|
|
MSN
|
moesin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MVP
|
major vault protein
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NBN
|
nibrin
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCOA6
|
nuclear receptor coactivator 6
|
|
NCOR1
|
nuclear receptor corepressor 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NEK6
|
NIMA-related kinase 6
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFE2L1
|
nuclear factor, erythroid 2-like 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPHS1
|
nephrosis 1, congenital, Finnish type (nephrin)
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OCLN
|
occludin
|
|
ORC2
|
origin recognition complex, subunit 2
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PDE10A
|
phosphodiesterase 10A
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE4C
|
phosphodiesterase 4C, cAMP-specific
|
|
PDE4D
|
phosphodiesterase 4D, cAMP-specific
|
|
PDHA1
|
pyruvate dehydrogenase (lipoamide) alpha 1
|
|
PDPK1
|
3-phosphoinositide dependent protein kinase 1
|
|
PEAK1
|
pseudopodium-enriched atypical kinase 1
|
|
PFN1
|
profilin 1
|
|
PGR
|
progesterone receptor
|
|
PHB2
|
prohibitin 2
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PLA2G4A
|
phospholipase A2, group IVA (cytosolic, calcium-dependent)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PML
|
promyelocytic leukemia
|
|
PNPLA8
|
patatin-like phospholipase domain containing 8
|
|
POLH
|
polymerase (DNA directed), eta
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKCZ
|
protein kinase C, zeta
|
|
PRKD1
|
protein kinase D1
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7
|
|
PTPRA
|
protein tyrosine phosphatase, receptor type, A
|
|
PTTG1IP
|
pituitary tumor-transforming 1 interacting protein
|
|
PXN
|
paxillin
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RARA
|
retinoic acid receptor, alpha
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RET
|
ret proto-oncogene
|
|
RGS18
|
regulator of G-protein signaling 18
|
|
RORA
|
RAR-related orphan receptor A
|
|
RPA2
|
replication protein A2, 32kDa
|
|
RPL13A
|
ribosomal protein L13a
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
SCN10A
|
sodium channel, voltage gated, type X alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SDC4
|
syndecan 4
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC3A2
|
solute carrier family 3 (amino acid transporter heavy chain), member 2
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLK
|
STE20-like kinase
|
|
SMAD2
|
SMAD family member 2
|
|
SMARCAL1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a-like 1
|
|
SNAPIN
|
SNAP-associated protein
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SPTLC1
|
serine palmitoyltransferase, long chain base subunit 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SSTR2
|
somatostatin receptor 2
|
|
SSTR5
|
somatostatin receptor 5
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STMN1
|
stathmin 1
|
|
SUDS3
|
suppressor of defective silencing 3 homolog (S. cerevisiae)
|
|
SYK
|
spleen tyrosine kinase
|
|
SYN1
|
synapsin I
|
|
TACC3
|
transforming, acidic coiled-coil containing protein 3
|
|
TARDBP
|
TAR DNA binding protein
|
|
TCP1
|
t-complex 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TH
|
tyrosine hydroxylase
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRIM28
|
tripartite motif containing 28
|
|
TRPC6
|
transient receptor potential cation channel, subfamily C, member 6
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTK
|
TTK protein kinase
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VIM
|
vimentin
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZNF148
|
zinc finger protein 148
|
